EU Financial Regulatory Q&A Database
Official Q&As published by EBA, ESMA, EIOPA and the ESA Joint Committee. Non-binding but treated as authoritative guidance by national competent authorities across the EU.
8,455 Q&As matching current filters · page 39 of 170
Do the ESAs have a view on how to incorporate short positions within the PAI indicators – should they be excluded, by being deducted from the PAI indicator calculations where the shorts relate to a br
SFDR
Answered 2022-11-17
What does “current value” mean?
SFDR
Answered 2022-11-17
Should an FMP still disclose the indicators applicable to investments in “sovereigns and supranationals” and “real estate assets” if the FMP makes no investments in sovereigns, supranationals and real
SFDR
Answered 2022-11-17
Calculation of Indicators 1 and 2 table 1 - Enterprise Value Question: For those indicators where Enterprise Value is used, how should we proceed if the Enterprise Value is negative?
SFDR
Answered 2022-11-17
If a financial market participant has to report on the consideration of ESG factors due to legally required information duties, such as under Directive (EU) 2016/2341, does this already qualify as "pr
SFDR
Answered 2022-11-17
Can the objective-aligned index designated as a reference benchmark under Article 9(1) SFDR, i.e. the “designated index” referred to in 9(1)(a) or 9(1)(b), be a broad market index?
SFDR
Answered 2022-11-17
Article 9(3) SFDR sets out disclosure requirements for “a financial product, [which] has a reduction of carbon emissions as its objective”. Does this also apply if a financial product has “reduction o
SFDR
Answered 2022-11-17
Are financial market participants allowed to define their own substantial contribution criteria for socially sustainable investments? Can a single financial market participant apply different interpre
SFDR
Answered 2022-11-17
Would a discretionary mandate that invests according to Investment Guidelines stipulated by the client be regarded as a financial product falling under Article 8 or Article 9 SFDR?
SFDR
Answered 2022-11-17
Do you consider the provisions regarding "underlying investment options" e.g., Article 21 Delegated Regulation to be relevant for portfolio management products?
SFDR
Answered 2022-11-17
How should "all investments" be understood? Gross asset value including cash, other assets, other liabilities? Or only actual investments, e.g., only private equity / private debt assets?
SFDR
Answered 2022-11-17
Would it be possible to have a financial product disclosing under Article 8 SFDR that makes sustainable investments with environmental objectives which are not (yet) taxonomy aligned?
SFDR
Answered 2022-11-17
Reporting Templates
(EU) No 2015/2450 - templates for the submission of information to the supervisory authorities · Art. Article 35 of SII Directive
Answered 2022-11-16
Solvency Capital Requirement (SCR)
(EU) No 2015/35 - supplementing Dir 2009/138/EC - taking up & pursuit of the business of Insurance and Reinsurance (SII) · Art. 189(3)
Answered 2022-11-16
Other
Guidelines on reporting and public disclosure · Art. Directive 2014/65/EU
Answered 2022-11-16
Own Funds (OF)
(EU) No 2017/1469 - standardised presentation format for the insurance product information document, Guidelines on classification of own funds · Art. N/A
Answered 2022-11-16
Settlement fails
Central Securities Depositories Regulation (CSDR) Regulation (EU) No 909/2014- PTR- CSDR
Answered 2022-11-15
Persons professionally arranging or executing transactions
Market Abuse Regulation (MAR) Regulation (EU) No 596/2014 - Market Intergrity
Answered 2022-11-15
Own Funds (OF)
(EU) No 2015/35 - supplementing Dir 2009/138/EC - taking up & pursuit of the business of Insurance and Reinsurance (SII) · Art. Article 1 (item 46); Article 260 (item 2 and 3)
Answered 2022-11-15
What is the meaning of indicating ‘the degree of freedom from the benchmark’ in Article 2a(d) of the Delegated Regulation?
PRIIPs
Answered 2022-11-14
How should actively-managed UCITS ETF be identified in the KID, and what information should be included in the “What is this product?” section of the KID? An actively-managed UCITS ETF should inform i
PRIIPs
Answered 2022-11-14
Does Article 2(2a)(d) of the Delegated Regulation require a UCITS or AIF to provide a clear indication of whether it is actively or passively managed?
PRIIPs
Answered 2022-11-14
What is the meaning of ‘whether this approach includes or implies a reference to a benchmark’ in Article 2a(d) of the Delegated Regulation? A UCITS or AIF managed in reference to a benchmark index is
PRIIPs
Answered 2022-11-14
What type of information should be included in the “What is this product?” section of the KID of index-tracking UCITS and index-tracking leveraged UCITS? For index-tracking UCITS, the following inform
PRIIPs
Answered 2022-11-14
Is it possible to show the complete name of the PRIIP when first mentioned in the KID and then simply refer to it as “the product” or “the Fund” thereafter?
PRIIPs
Answered 2022-11-14
It should be clarified in Annex I of the Delegated Regulation, where the name of the group should be included and whether it should be shown in bold.
PRIIPs
Answered 2022-11-14
Is it possible to signpost to a glossary?
PRIIPs
Answered 2022-11-14
Are the redemption prices of open-ended real estate AIFs "prices" within the meaning of point 5 of Annex II of the Delegated Regulation?
PRIIPs
Answered 2022-11-14
How should UCITS ETFs be identified in the KID, and what information should be included in the “What is this product?” section of the KID? A UCITS ETF should use the term ‘UCITS ETF’ which identifies
PRIIPs
Answered 2022-11-14
Could you clarify for which intermediate holding periods should we show performance scenarios during the lifetime of a product? (E.g.: 1.1 years product, with remaining lifetime of 9 months). We belie
PRIIPs
Answered 2022-11-14
If the benchmark is changed, how should the chart of past performance be displayed for the period preceding the change?
PRIIPs
Answered 2022-11-14
Can a fund with multiple share classes use the price history of an existing share class when a new share class is created rather than use the price history of a benchmark?
PRIIPs
Answered 2022-11-14
For the identification of additional shorter sub intervals in point 7(b) of Annex IV of the Delegated Regulation, does this mean only the sub intervals that are truncated by the end of the time period
PRIIPs
Answered 2022-11-14
In terms of the identification of sub intervals in point 7(a) of Annex IV of the Delegated Regulation are these all contained within in the time period defined in point 6 of Annex IV?
PRIIPs
Answered 2022-11-14
What is the relationship between point 11 of Annex IV and Article 15 of the Delegated Regulation?
PRIIPs
Answered 2022-11-14
When several versions of a benchmark are available which differ in the approach taken to reinvestment of revenues, which version should be used in the past performance chart?
PRIIPs
Answered 2022-11-14
Point 19 of Annex VIII of the Delegated Regulation states that “In the case of mergers referred to in Article 2(1)(p)(i) and (iii) of Directive 2009/65/EC, only the past performance of the receiving U
PRIIPs
Answered 2022-11-14
Should existing retail investors within a UCITS umbrella fund, who switch or exchange units in one sub-fund for units in another, be provided with the KID for the sub-fund in which they are going into
PRIIPs
Answered 2022-11-14
Is it possible to alter the prescribed wording in the KID template for OTC derivatives? It is recognised in point 6a of Annex III and point 12 of Annex V of the Delegated Regulation that some of the s
PRIIPs
Answered 2022-11-14
[Question deleted] (Revised 21 December 2022) 3. Which form and name should the ‘specific information on each underlying investment option’, referred to in Article 14 of the Delegated Regulation, tak
PRIIPs
Answered 2022-11-14
Should individual KIDs be prepared for each class of units or shares within a UCITS or AIF?
PRIIPs
Answered 2022-11-14
Prior to 1 January 2023 is it possible to prepare a KID based on the new requirements in Commission Delegated Regulation (EU) 2021/2268, for example for a product launched between September and Decemb
PRIIPs
Answered 2022-11-14
For autocallables, for an early call scenario, what time periods should be used when calculating the performance scenarios and cost figures?
PRIIPs
Answered 2022-11-14
What should be displayed in the bar chart for years when there is no data?
PRIIPs
Answered 2022-11-14
In the Delegated Regulation, the VEV for flexible funds is determined by taking the maximum of the three following options: 1. VEV of the returns of the share class self-history, 2. VEV of the returns
PRIIPs
Answered 2022-11-14
Does the requirements in Articles 6(1) and 9 of the PRIIPs Regulation mean that past performance disclosed regarding a benchmark index should be consistent with past performance disclosure in other in
PRIIPs
Answered 2022-11-14
[Question deleted] (Revised 21 December 2022) 8. The paragraph which comes directly after the heading “Table 1” (“The person advising on or selling you this product …”) is duplicate in view to Elemen
PRIIPs
Answered 2022-11-14
Point 52(h) of Annex VI indicates that transaction costs are included in the ‘other ongoing costs’. What does this mean in terms of where transaction costs should be included in table 2 ‘Composition o
PRIIPs
Answered 2022-11-14
Do the rules concerning the UCITS key investor information document (KIID) still apply?
PRIIPs
Answered 2022-11-14
The UCITS KIID framework introduced the concept of “Absolute Return Funds”. For these types of funds, there is no need to select an appropriate risk benchmark and the UCITS SRRI is determined in its e
PRIIPs
Answered 2022-11-14
Source: EBA Single Rulebook Q&A, ESMA Q&A, EIOPA Q&A, ESA Joint Q&As. Updated weekly. Q&As are non-binding guidance.
📋 Track EU financial regulation continuously
Forseti monitors EU financial regulation and delivers personalised alerts anchored to verified official sources.
14-day free trial. No credit card required.